Activation of Akt-mTORC1 signalling reverts cancer-dependent muscle wasting.
Alessia GeremiaRoberta SartoriMartina BaraldoLeonardo NogaraValeria BalmacedaGeorgia Ana DumitrasStefano CiciliotMarco ScalabrinHendrik NolteBert BlaauwPublished in: Journal of cachexia, sarcopenia and muscle (2021)
Here, we show that activation of Akt-mTORC1 signalling is sufficient to completely revert cancer-dependent muscle wasting. Intriguingly, these results show that skeletal muscle maintains its anabolic capacities also during cancer cachexia, possibly giving a rationale behind some of the beneficial effects observed in exercise in cancer patients.